Clinical trial
Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis.
NCT05883891 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis.
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2017
- Completion date
- November 30, 2022
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcoholic hepatitis